Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Remote training and tiny sensors could revolutionize low vision care

NCT ID NCT06107881

Symptom relief Sponsor: University of California, Los Angeles Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study compares telerehabilitation (remote training) to in-office care for adults with low vision who have received new magnification devices or assistive apps. Researchers will also use Bluetooth sensors to monitor if patients stop using their devices, aiming to provide timely support. The goal is to improve quality of life by making reading and daily tasks easier, while overcoming barriers like travel and lack of specialists.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Low vision rehabilitation (training with magnification devices and assistive mobile apps)
What this could lead to
If successful, this could make low vision training more accessible via remote sessions, improving daily reading and tasks for many people.
What could go wrong
This is a behavioral study, not a drug trial, so benefits may be modest. Results depend on participant engagement and may not apply to all types of vision loss.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 350 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2023

Expected to finish

Jun 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * adults with any level of vision loss due to any ocular disease who are age 18 and older, and who have received new magnification device(s) for the first time (i.e., hand-held optical magnifiers, portable electronic video magnifiers, high near add powers of +4.00 or greater, visual assistive mobile apps for their smartphone/tablet, some stand magnifiers and CCTVs) from one of our participating low vision rehabilitation sites at the four academic centers and one private practice. Exclusion Criteria: * schedules not permitting participation in planned study visits (including planning to move far from their clinical provider's office within the first 4-months of the study (i.e., cannot attend in-office visits) or take extended vacation that would not allow them to complete study procedures during the first four months of the study period), * inability to understand study procedures or communicate responses to visual stimuli in a consistent manner (greater than mild cognitive impairment as per TICS), * substance abuse, * significant hearing loss (unable to hear communication by phone or via videoconferencing), * significant medical condition likely to limit participation or lifespan, * individuals who require other types of LVR training or intervention (e.g., psychosocial). * For Bluetooth low energy beacon sensors, exclusion would occur if their magnifier device has features that would not work in conjunction with the beacon sensors: (1) hands-free and do not have a place where the patient's hand is holding the device during use (therefore, they would not register a significant change in temperature), (2) no surface area of at least 1"x1" to which the beacon sensor could be attached without interfering with the device, or (3) use of visual assistive mobile apps only.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Low vision are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

vision disorder Vision, Low

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Low vision Low vision AIDS

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    9 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Boston University Eye Associates, Inc.

    NOT_YET_RECRUITING

    Brockton, Massachusetts, 02301, United States

  • Chan Family Optometry

    NOT_YET_RECRUITING

    Grass Valley, California, 95945, United States

  • Frank Stein & Paul S. May Center for Low Vision Rehabilitation at The Eye Institute

    NOT_YET_RECRUITING

    San Francisco, California, 94102, United States

  • Mid-Michigan Eye Care

    NOT_YET_RECRUITING

    Midland, Michigan, 48640, United States

  • New England College of Optometry

    NOT_YET_RECRUITING

    Boston, Massachusetts, 02115, United States

  • See What You Miss Optometry

    NOT_YET_RECRUITING

    Santa Monica, California, 90401, United States

  • Southern Califonia College of Optometry

    NOT_YET_RECRUITING

    Fullerton, California, 92831, United States

  • UCLA Stein Eye Institute

    RECRUITING

    Los Angeles, California, 90095, United States

  • University of Nebraska: Weigel Williamson Center for Visual Rehabilitation at the Truhlsen Eye Institute

    NOT_YET_RECRUITING

    Omaha, Nebraska, 68198, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.